VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection. Cancer Res. 2016 07 01; 76(13):3684-9.
View in:
PubMed
subject areas
Adenocarcinoma
Animals
CD8-Positive T-Lymphocytes
Colorectal Neoplasms
Cytokines
Female
Flow Cytometry
Humans
Inducible T-Cell Co-Stimulator Ligand
Lymphocyte Activation
Mice
Mice, Inbred BALB C
Mice, Nude
Receptors, Antigen, T-Cell
Receptors, OX40
Signal Transduction
T-Lymphocytes, Regulatory
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
authors with profiles
JAMES P ALLISON
PADMANEE SHARMA